About EOCI

EOCI has a demonstrated track record of over 13 years in the CME industry. Our reputation is a result of business integrity and professional agility, as well as resourcefulness and creativity.

In addition to the 25 to 30 CME programs we develop annually, EOCI produces other high-calibre specialist-focused annual congresses in Mont-Tremblant, and Montreal:

Arrhythmia Update Plus 2019

February 6 to February 9, 2019

Conference Educational Objectives

Following this program participants will be able to:

  • Explore the history and evolution of AF management in the past century
  • Examine additional outcomes from the COMPASS trial including subgroup and cost-effectiveness analyses
  • Analyze the evidence and expert opinion on arrhythmias and heart failure
  • Examine recent findings from stroke prevention trials including ESUS, POINT, and studies on PFO closure
  • Share best practices on the delivery of care in heart failure
  • Discuss practical approaches for mitigating anti-diabetic medication side effects
  • Improve skills for interpreting challenging echocardiograms
  • Examine strategies to optimize medical therapies at HF discharge
  • Discuss the pros and cons of ablation vs. medical therapy in HF patients with atrial arrhythmia
  • Explore the optimal management of acute stroke through cases that are relevant to cardiologists
  • Analyze the evidence and expert opinion on AF cardioversion
  • Examine the findings of recent heart failure trials
  • Discuss optimal management of atrial fibrillation in patients with heart failure
  • Understand the role of AF ablation for the prevention of stroke and mortality
  • Explore the role of cardiologists in the contemporary management of diabetes
  • Analyze the evidence and expert opinion on the optimal management of PAD
  • Discuss strategies for the management of acute AF in the emergency department
  • Examine the outcomes of late-breaking trials for antihyperglycemic agents, presented at AHA 2018
  • Examine strategies for the management of high-risk and vulnerable AF patients
  • Explore challenging cases in the management of syncope
  • Understand the evolving role of anticoagulant therapy in patients with CAD and AF post-PCI
  • Examine the role of inflammation and lipids in residual CV risk
  • Examine different hybrid therapy options for the suppression of AF and discuss the need to validate those options through prospective studies
  • Discuss practical aspects of NOAC dosing in patients who experience bleeding events
  • Discuss contemporary strategies for the management of syncope

Subscribe to get the latest updates

Receive the latest news on the Arrhythmia Update Conference directly in your mailbox.